These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 313689)

  • 21. Restoration of E-rosette formation by levamisole and its abrogation by autochthonous serum from cattle with squamous cell carcinoma of horn.
    Dhingra VK; Gupta RK; Sadana JR
    Res Vet Sci; 1982 Sep; 33(2):142-5. PubMed ID: 6983096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Individual reactivity to Imuran, antithymocytic globulin and levamisol].
    Korcáková L; Rovenský J; Pekárek J; Holub M; Kocandrle V
    Cas Lek Cesk; 1982 Sep; 121(38-39):1180-3. PubMed ID: 6982754
    [No Abstract]   [Full Text] [Related]  

  • 23. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects.
    Luyckx M; Cazin M; Brunet C; Cazin JC; Devulder B; Gosselin P; Adenis L; Cappelaere P; Granier AM; Demaille A
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):467-9. PubMed ID: 6608036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The assessment of cellular immunity parameters in patients with breast cancer and lymphogranulomatosis during dynamic treatment].
    Baldueva IA; Pukhova ZhK; Gavrilenkova LP; Mosberger ID
    Vopr Onkol; 1992; 38(7):787-92. PubMed ID: 1300783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration by levamisole of rosette-forming cells inhibited by histamine, db-CAMP and adenosine.
    De Cock W; De Cree J; Verhaegen H
    J Immunopharmacol; 1978-1979; 1(1):115-22. PubMed ID: 233842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effect of levamisole on E-rosette formation by T-lymphocytes of uremic patients.
    Modai D; Peller S; Cohen N; Shaked U; Kaufman S
    Isr J Med Sci; 1983 Mar; 19(3):289-91. PubMed ID: 6303981
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: In-vitro restoration by levamisole of thymus-derived lymphocyte functions in Hodgkin's disease.
    Verhaegen H; De Cock W; De Cree J; Verbruggen F; Verhaegen-Declercq M; Brugmans J
    Lancet; 1975 Apr; 1(7913):978. PubMed ID: 48151
    [No Abstract]   [Full Text] [Related]  

  • 30. Total and 'active' E-rosette forming T lymphocytes in case of lymphoma: a preliminary communication.
    Kumar R; Sharma VK; Goel S; Mehrotra ML; Nagar AM
    Indian J Cancer; 1986 Sep; 23(3):185-91. PubMed ID: 3497863
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: In-vitro resotration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease.
    Biniaminov M; Ramot B
    Lancet; 1975 Feb; 1(7904):464. PubMed ID: 48661
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
    Sansoni P; Rossetti A; Valente G; Butturini U
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
    [No Abstract]   [Full Text] [Related]  

  • 33. Spontaneous rosette formation in vitro under the effect of agents affecting the cyclic nucleotide system of circulating lymphocytes of normal subjects.
    Kalmár L; Gergely P; Nékám K; Láng I; Petrányi G
    Acta Med Acad Sci Hung; 1978; 35(1):21-8. PubMed ID: 216213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosette formation in Hodgkin's disease.
    Swain A; Trounce JR
    Oncology; 1974; 30(6):449-57. PubMed ID: 4549695
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of human red blood cells in lymphogranulomatosis by the H-rosette formation test].
    Pecze K; Telek B; Rák K
    Orv Hetil; 1984 Apr; 125(16):935-7. PubMed ID: 6609331
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of advanced Hodgkin's disease in remission.
    Klener P; Hausner P; Donner L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):213-7. PubMed ID: 6179821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enkephalins--enhancement of active T-cell rosettes from lymphoma patients.
    Miller GC; Murgo AJ; Plotnikoff NP
    Clin Immunol Immunopathol; 1983 Mar; 26(3):446-51. PubMed ID: 6603310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M; Piccioli E; Migliorati T; Ruggeri G
    Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II; Skakal'skaia LM
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract]   [Full Text] [Related]  

  • 40. Placental isoferritin-associated p43 in pregnancy and breast cancer. Minireview.
    Rosen HR
    Neoplasma; 1996; 43(6):357-62. PubMed ID: 8996558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.